Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.034 | 0.9 |
mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |